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Abstract 
Introduction and Aims: Reducing smoking prevalence among Indigenous Australians is a vital part of 
closing the health gap between Indigenous and non‐Indigenous Australians. Community‐controlled 
health clinics are an important setting for delivering smoking cessation advice and assistance. This 
study measured tobacco and e‐cigarette use, knowledge of smoking‐related health effects, motivations 
to quit and interest in cessation aids. 
Design and Methods: Clients of Aboriginal & Torres Strait Islander Community Health Service dental 
clinics in Southeast Queensland (n = 421) completed a brief written questionnaire while in the waiting 
room. 
Results: Nearly half (n = 184, 47%) of the participants currently smoked daily, of which 9% (n = 7) 
currently used e‐cigarettes. Few smokers (8%, n = 13) had no intention to quit smoking. For current 
smokers, previously used quit methods were abrupt cessation (42%, n = 78), nicotine replacement 
therapies (NRT; 25%, n = 45), prescription medications (23%, n = 43), e‐cigarettes (9%, n = 17) and 
other methods (3%, n = 6). Current smokers were most interested in cutting down (85%, n = 110), 
abrupt cessation (75%, n = 98) and free NRT (72%, n = 101). Fewer (34%, n = 36) were interested in 
purchasing NRT for smoking cessation. 
Discussion and Conclusions: Our study found there was interest in accessing smoking cessation aids 
among the clients of this community‐controlled health clinic, particularly if provided free of charge. 
Embedding smoking cessation advice and assistance into a range of community‐controlled health 
clinics could provide opportunities for addressing the high smoking prevalence among Indigenous 
Australians. 
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Introduction 
Smoking rates have declined considerably in the general population over the last decade; 
however this has been less apparent for Indigenous Australians. While smoking prevalence in 
this population has reduced by 10% over this period, 41% continue to smoke daily 1, 2. 
Tobacco is a key contributor to health inequalities between Indigenous and non‐Indigenous 
Australians 3. Tobacco smoking is the most preventable cause of ill health and reducing 
smoking has been identified as a priority area for closing the gap in health outcomes between 
Indigenous and non‐Indigenous Australians 4. Smoking is an established risk factor for 
adverse oral health outcomes including chronic gum disease (periodontitis), impaired oral 
wound healing, and for diseases with significant morbidity and mortality such as oral and 
oropharyngeal cancer 5, 6. The high prevalence of smoking among Indigenous Australians is a 
likely contributor to the poorer oral health this population experiences 7. 
Multiple factors contribute to the high rates of tobacco smoking among Indigenous 
Australians such as socio‐economic inequities, education and social norms 8, 9. Similar to 
non‐Indigenous smokers, Indigenous smokers cite stress alleviation as a primary reason for 
smoking 10, 11. Smoking among some Indigenous communities is seen as a social norm with 
traditional origins 12. A tradition, which is still observed today in remote communities, is the 
chewing of the leaves of native tobacco plants 13. The dried leaves which can contain up to 
8% nicotine (6% higher than commercially available cigarettes), are rolled up and dipped in 
leaves, bark and ash 13. Evidence is scarce on the health impact of traditional tobacco 
chewing 13-15, and little is known about the prevalence of use in urban settings. 
Population level policies to reduce smoking include taxation, advertising bans, anti‐smoking 
mass media campaigns and smoke free public spaces 1, 2. Targeted health promotion 
programs, such as the Deadly Choices program, uses community events, mass and social 
media campaigns to encourage Indigenous people to engage in health‐promoting 
behaviour 16. Individual level strategies to increase smoking cessation include behavioural 
support (e.g. Quitline counselling or group‐based quit programs) and cessation aids [e.g. 
nicotine replacement therapies (NRT), varenicline or bupropion] 17. However, use of 
cessation aids is lower among Indigenous Australian smokers compared to non‐Indigenous 
Australians 18. A comprehensive approach that utilises both population level health promotion 
strategies and individual cessation assistance is likely to be most effective at increasing 
cessation attempts and success among Indigenous smokers 19. 
Previous qualitative research among urban Indigenous smokers found that there was interest 
in trying nicotine replacement products, including novel products such as electronic cigarettes 
(e‐cigs) 20. Medical practitioner endorsement of cessation aids was seen as important to 
encouraging use. Therefore, community‐controlled health clinics could be an important 
setting for delivery of smoking cessation advice and assistance to Indigenous smokers. To 
expand on current knowledge, this study used quantitative methods to describe the current 
use of cigarettes, vaping products (e‐cigs) and pituri (chewing tobacco) in a sample of 
Indigenous Australians attending dental clinics of a community‐controlled health service. An 
additional aim was to investigate the participants’ knowledge of general and oral health 
effects of smoking, motivations to quit, methods used for past quit attempts and interest in 
using different quit methods for a future quit attempt. 
Methods 
Participants 
Participants in this study were clients who attended two Aboriginal & Torres Strait Islander 
Community Health Service dental clinics located in urban areas of Southeast Queensland 
(Woolloongabba and Woodridge), Australia between June 2014 and June 2015. All 
participants were of Aboriginal and/or Torres Strait Islander background. 
This research was part of a larger research collaboration investigating the oral health of 
Indigenous people and the study was conducted in partnership with the Aboriginal & Torres 
Strait Islander Community Health Service to ensure the study was culturally appropriate. The 
aim of this project was to investigate smoking in a dental setting as smoking is an important 
risk factor to oral health. All clients attending the Aboriginal & Torres Strait Islander 
Community Health Service dental clinics were invited to participate in this study regardless 
of their smoking status. Following their dental appointment, adult clients (over 18 years of 
age) were invited to participate in this study and presented with the questionnaire and 
participant information and consent form. Potential participants were asked to place the 
consent form and questionnaire either completed, or blank if they chose not to participate, in 
a collection box in the dental clinic reception. Only the research team collected the completed 
and blank forms from the box. Participation was voluntary and patients who declined to 
participate were accounted for by counting the blank questionnaires to calculate a response 
rate. 
Measures 
Participants’ demographics (age and gender) and smoking status (current smokers, never 
smokers, ex‐smokers) were collected. Socio‐economic status was measured with Socio‐
Economic Index for Areas using the location of the dental clinic 21. Socio‐Economic Index 
for Areas was coded in deciles by postcode with one indicating the most disadvantaged 10% 
of postcodes and 10 the 10% of least disadvantaged postcodes 21. 
For ex‐smokers, information was collected regarding quitting methods, quitting date and 
willingness of these participants to assist current smokers to quit smoking. 
For current smokers nicotine dependence was measured by the Heaviness of Smoking 
Index22. Confidence in quitting smoking (quitting self‐efficacy), past cessation attempts and 
the methods used, awareness of general and oral health effects of smoking and willingness to 
accept advice from dental practitioners were collected. Participants were asked if they had 
ever heard of e‐cigs and if they had ever tried e‐cigs or pituri (native chewing tobacco). The 
questionnaire asked about participants’ interest in a range of smoking cessation methods such 
as NRT (when provided at no cost and at a cost to the smoker), abrupt cessation (cold 
turkey), cutting down, Quitline counselling, e‐cigs, prescription medications, one‐on‐one 
counselling, group‐based quit programs and help from community members who had 
successfully quit smoking. 
Statistical analysis 
Frequency distributions and cross‐tabulations by smoking status were analysed using SPSS, 
version 24 (IBM Corporation, Armonk, NY, USA). Pearson’s χ2 test or Fisher’s exact test was 
used to assess associations between current smokers and general and oral health status, 
quitting behaviours and participant characteristics. Response rates vary by questions as partly 
completed questionnaires were included in the analysis. 
Ethics 
Human Research Ethics Approval was granted by the Behavioural and Social Sciences 
Ethical Review Committee of the University of Queensland (no. 2014000916). 
Results 
Demographics, smoking behaviours and health status 
Four hundred and twenty‐one participants took part in this anonymous questionnaire. The 
overall response rate was 92.5%. Two participants were under 18 years of age and 29 were 
missing responses to smoking status. These participants’ responses were excluded from the 
analysis giving a total study sample size of 390. 
Participants’ demographics and self‐reported smoking status are presented in Table 1. 
Participants ranged in age from 18 to 80 years with a median age of 37 years (interquartile 
range 21 years). Overall, 47% (n = 184) of participants were current smokers and 19% 
(n = 75) were former smokers. Significantly more participants from the Woodridge clinic 
were self‐reported current smokers (P < 0.05) and participants aged over 61 years were never 
smokers (P < 0.05).
 Table 1. Participant demographics and self‐reported smoking status (n = 390) 
 
Never 
smoker, n (%) 
Current 
smoker, n (%) 
Former 
smoker, n (%) 
Total, n Missing, n (%) P value 
Total 131 (33.6) 184 (47.2) 75 (19.2) 390 
  
Clinic 
      
Woolloongabba 84 (38.2) 89 (40.5) 47 (21.4) 220 0 (0.0) *0.010 
Woodridge 47 (27.6) 95 (55.9) 28 (16.5) 170 
  
Age, years 
      
18–40 75 (35.7) 99 (47.1) 36 (17.1) 210 21 (5.4) *0.021 
41–60 36 (27.1) 69 (51.9) 28 (21.1) 133 
  
61+ 14 (53.8) 5 (19.2) 7 (26.9) 26 
  
Gender 
      
Female 83 (37.2) 92 (41.3) 48 (21.5) 223 14 (3.6) 0.061 
Male 46 (30.1) 82 (53.6) 25 (16.3) 153 
  
* Statistically significant. 
The median number of cigarettes smoked per day by self‐reported current smokers was 15 
(interquartile range 10) and most current smokers had very low Heaviness of Smoking Index 
dependency score (75%, n = 102). 
A majority of smokers reported currently experiencing general health problems 
(71%, n = 116) or oral health problems (80%, n = 130) self‐attributed to their smoking. Types 
of smoking‐related general health problems identified were respiratory (47%, n = 86), 
circulatory (30%, n = 55), cardiac (23%, n = 42) and other (9%, n = 17) problems (e.g. 
reduced fitness). Oral health problems that were identified included discoloured teeth 
(63%, n = 116), bad breath (59%, n = 108), reduced sense of taste (41%, n = 75), bleeding 
gums (28%, n = 52), gum disease (27%, n = 49) and loose teeth (27%, n = 49). Almost all 
(98%, n = 165) of the current smokers were aware that smoking could affect their oral health. 
Participant knowledge and use of e‐cigarettes and pituri 
The majority (79%, n = 292) of participants had heard of e‐cigs before, with only 20% 
(n = 70) having tried one previously (Table 2). Overall 2% (n = 7) of the total sample 
population were currently using e‐cigs and few (5%, n = 8) had used pituri. Significantly 
more current and former smokers had heard of and previously tried e‐cigs, than those who 
had never smoked cigarettes (P < 0.001). 
Table 2. Participant knowledge and use of e‐cigarettes and pituri (n = 390) 
 
Current 
smoker, n (%) 
Former 
smoker, n (%) 
Never 
smoker, n(%) 
Total, n Missing, n (
%) 
P value 
E‐cigarettes        
Ever heard 
of 
No 25 (14.5) 11 (15.3) 40 (32.5) 76 (20.7) 22 (5.6) *<0.001 
Yes 148 (85.5) 61 (84.7) 83 (67.5) 292 (79.3) 
  
Ever used No 106 (67.9) 59 (84.3) 112 (92.6) 277 (79.8) 43 (12.4) *<0.001 
Yes 50 (32.1) 11 (15.7) 9 (7.4) 70 (20.2) 
  
Currently 
use 
regularly 
No 158 (95.8) 69 (100.0) 121 (100.0) 348 (98.0) 35 (9.0) 0.315 
Yes 7 (4.2) 0 (0.0) 0 (0.0) 7 (2.0) 
  
Pituri 
       
Ever used No 69 (92.0) 27 (93.1) 50 (100.0) 146 (94. 236 (60.5) 0.128 
 
Yes 6 (8.0) 2 (6.9) 0 (0.0) 8 (5.2) 
  
* Statistically significant. 
Quit intention and motivations 
Most self‐reported current smokers (66%, n = 122) had previously tried to quit smoking. This 
was significantly higher for female participants, with 77% (n = 71) of females and 57% 
(n = 47) of males having previously tried to quit (P < 0.05). The majority of self‐reported 
current smokers (n = 97, 62%) were interested in quitting but had not set a quit date. Around 
a quarter, (24%, n = 37) were ready to quit but had not set a quit date, and 6% (n = 10) had set 
a quit date. A low proportion (8%, n = 13) had no intention to quit smoking. 
Participants reported that they would be motivated to quit if their dental professional told 
them smoking was causing unhealthy gums and tooth loss (53%, n = 98), lesions in the mouth 
(52%, n = 96), discoloured teeth (45%, n = 82) and problems with healing (43%, n = 79). 
Previous and future quit attempts 
For self‐reported current smokers, previously used quit methods were abrupt cessation 
(42%, n = 78), NRT (25%, n = 45), prescription medications (23%, n = 43), e‐cigs 
(9%, n = 17) and other methods (3%, n = 6). Former smokers reported that they had used 
abrupt cessation (65%, n = 48), NRT (11%, n = 8) and other methods (24%, n = 18). 
The interventions current smokers were most interested in using for a future quit attempt 
were: cutting down (85%, n = 110), abrupt cessation (75%, n = 98) and cessation medications 
(61%, n = 76) (Table 3). Most former smokers (53%, n = 40) indicated that they would be 
interested in helping another smoker quit. Similar proportions of 18–40 (51%, n = 18) and 
41–60‐year‐old (50% n = 13) former smokers wanted to assist others to quit smoking, but all 
former smokers aged over 60 years (n = 7) wanted to assist others to quit (P < 0.05).
 Table 3. Self‐reported current smokers’ (n = 184) interest in smoking cessation interventions 
 
Not 
interested, n (%) 
Somewhat 
interested, n (%) 
Very 
interested, n (%) 
Total, n Missing, n(%) 
Free NRT 39 (27.9) 36 (25.7) 65 (46.4) 140 44 (23.9) 
Paid NRT 71 (66.4) 21 (19.6) 15 (14.0) 107 77 (41.8) 
Cold Turkey 32 (24.6) 49 (37.7) 49 (37.7) 130 54 (29.3) 
Cutting 
down 
19 (14.7) 42 (32.6) 68 (52.7) 129 55 (29.9) 
Quitline 66 (58.9) 31 (27.7) 15 (13.4) 112 72 (39.1) 
E‐cigarette 54 (45.4) 37 (31.1) 28 (23.5) 119 65 (35.3) 
Medications 48 (38.7) 43 (34.7) 33 (26.6) 124 60 (32.6) 
One‐on‐one 
support 
67 (57.8) 32 (27.6) 17 (14.7) 116 68 (37.0) 
Group 
support 
77 (68.8) 21 (18.8) 14 (12.5) 112 72 (39.1) 
Community 
person 
support 
64 (55.2) 33 (28.4) 19 (16.4) 116 68 (37.0) 
NRT, nicotine replacement therapy. 
Discussion 
Demographics, smoking behaviours and health status 
This study described the current smoking behaviours, quit intentions and motivations to quit 
of clients attending two urban Indigenous community‐controlled dental clinics. The majority 
of the participants were currently daily smokers or formers smokers from younger age 
groups, which is consistent with the broader literature 1, 2. Similar to national smoking rates 
(41% current daily smokers) 23, the prevalence of smoking for Indigenous Australians in this 
study was 47%. Additionally, the prevalence of smoking rates in Indigenous Australians can 
be higher in sub‐groups such as those in remote locations and pregnant women 24. Compared 
to a similar study for the general population attending dental clinics, Indigenous smokers in 
this study had higher self‐reported general and oral health problems attributed to their 
smoking 23. This finding is similar to the broader literature finding a health gap between 
Indigenous and non‐Indigenous Australians 4. 
Smoking prevalence differed between the study sites. This may be due to the socio‐economic 
differences between the locations, with different Socio‐Economic Index for Areas scores for 
Woolloongabba (7—high socio‐economic status) and Woodridge (1—low socio‐economic 
status) 25. Questionnaires were also completed in the waiting room of dental clinics and this 
setting may have influenced patients’ answers. For example, there is potential for the 
participants in a health setting to over‐report socially desirable behaviour, such as interest in 
quitting smoking. However, use of self‐completed questionnaires, rather than interviewer‐
delivered would have limited this potential bias 26. Another limitation of the setting was that 
some participants may have run out of time to complete the questionnaire fully, data were 
missing on some items. 
Alternative tobacco knowledge 
Most of the sample had heard of e‐cigs, a quarter of the sample had tried them previously, but 
few were current users. The prevalence of e‐cig awareness and use in this sample of 
Indigenous Australians was similar to that of smokers in the general Australian population; 
with two‐thirds aware of e‐cigs, 20% having tried before and 7% current users of e‐cigs 27. 
More than half of our sample of Indigenous smokers were interested in using e‐cigs. Previous 
qualitative research among Indigenous smokers found that some participants who were not 
willing to use NRT were willing to use novel nicotine products such as e‐cigs 20. While e‐
cigs containing nicotine are not generally available in Australia, they present a new option for 
addressing tobacco‐related harms in this priority population that should be investigated 
further. 
Pituri use was uncommon in this urban population. Pituri use is a tradition more commonly 
practised in remote central Australia 13. Since colonisation and the introduction of 
commercial tobacco products, the use of pituri has declined 14. The low proportion of pituri 
users in our sample is likely to be due to the urban setting of our study 13. Our study only 
measured past use of pituri and not interest in future use, however a previous qualitative 
study among urban Indigenous smokers found very few were willing to use an oral snuff 
product which is used in a similar way (placed in the mouth), suggesting there may be less 
potential for pituri to be used for harm reduction purposes 20. 
Tobacco harm reduction has gained more attention in recent years due to the emergence of e‐
cigs. The focus of tobacco harm reduction is on reducing the burden of disease associated 
with nicotine use without necessarily completely eliminating it, such as by encouraging 
smokers to switch to lower risk nicotine products 28. There is debate about whether harm 
reduction approaches should be included in Australian tobacco control policy. Nevertheless, 
harm reduction approaches could provide a pathway for heavily dependent smokers and those 
with low quitting self‐efficacy, who are often over‐represented among priority populations, to 
reduce the impact of their nicotine use 28, 29. Potential tobacco harm reduction products 
include e‐cigs and smokeless tobacco/pituri. E‐cigs may still confer some health risk, but 
emerging evidence suggests these are much lower than the risks of smoking cigarettes 28. 
While there is little data available on the health effects of pituri use, it is likely to be less 
harmful than cigarette smoking because most of the harms of smoking are due to inhaling the 
by‐products of combusted tobacco 30. The prevalence of e‐cigs and pituri use has not 
previously been reported for an urban Indigenous population. 
Quit intention and motivations 
Compared to a general population sample of Australian smokers also recruited from dental 
clinics 23, fewer Indigenous Australians in this study had previously used cessation aids such 
as NRT 23. The most commonly used cessation methods were abrupt cessation and cutting 
down. Lower use of cessation aids among Indigenous smokers compared to the general 
population has previously been reported in the literature 9. Our study did not collect data on 
why participants did not use cessation aids in previous quit attempts, however other 
qualitative research among Australian Indigenous former smokers found that a lack of trust 
and negative attitudes towards smoking cessation aids were barriers to use 31. In addition to 
scepticism about their efficacy, these products were viewed as an alternate addiction, rather 
than a cure, and their use was viewed as evidence of a lack of willpower. The importance of 
having the right mindset was also viewed by participants as a key factor in successful 
quitting. Similar findings have been reported in general population samples of current 32 and 
former smokers 33 in Australia. 
Previous and future quit attempts 
Few of the smokers in our study had no intention to quit smoking and many recognised that 
smoking was adversely affecting their general and oral health. This presents medical and 
dental practitioners with an ideal opportunity to deliver information and contextualise health 
problems attributed to smoking as a motivator to quit smoking. The five ‘A’s approach is a 
brief intervention that has been developed for delivery by a range of health practitioners, 
including oral health practitioners, and is a simple framework in which the findings of this 
study can be applied to improve cessation support 34, 35. 
Unassisted cessation was the method most of the current study’s participants were interested 
in using for a future quit attempt. However, while less than a quarter of the sample had 
previously used NRT as a quit method, over two‐thirds were interested in using it in the 
future. This suggests that despite the low previous use of cessation aids, the proportion of 
Indigenous smokers who are open to using them is much higher. Because NRT use 
significantly increases the likelihood of successfully quitting smoking 36, health practitioners, 
including oral health practitioners, should encourage all smokers to use these products when 
quitting smoking and provide education and training in how to use them correctly. 
Our results showed considerably fewer participants were interested in buying NRT than were 
interested in accessing it for free. Nicotine patches are available at no cost to Indigenous 
Australians through schemes such as the Pharmaceutical Benefits Scheme and ‘closing the 
gap’ funding 37. Other NRT products are not currently subsidised via the Pharmaceutical 
Benefits Scheme and generally must be purchased at full cost to the smoker, however some 
Indigenous medical services self‐fund non‐subsidised NRTs 38. Our findings confirm this is 
an important initiative and increases interest in using these cessation aids. Health 
practitioners should educate Indigenous smoking patients about the subsidies that are 
available for cessation aids, including NRT. Discussing the relative cost of non‐subsidised 
NRTs compared to the cost of cigarettes may also help contextualise these products as lower 
cost than cigarettes. 
For Indigenous smokers, behavioural support and cessation aids provided in primary health‐
care settings have been shown to be most effective and culturally appropriate when integrated 
into Aboriginal and Torres Strait Islander health services 39. These clinics provide culturally 
appropriate healthcare and are more acceptable to Indigenous people than mainstream 
services 40. Medical and dental practitioners working in Indigenous health services such as 
the setting of the current study should work together to provide multidisciplinary smoking 
cessation support. Further research should investigate shared‐care and referral pathways for 
smoking cessation support within Indigenous health services that offer multiple health 
services. 
Conclusion 
With the prevalence of current daily smoking remaining persistently high for Indigenous 
Australians, cessation interventions that are effective and acceptable to Indigenous smokers 
are crucial to begin to reduce the burden of smoking‐related disease. Health practitioners can 
utilise brief intervention methods to educate their patients of the oral health effects of 
smoking and the effectiveness of current cessation therapies and provide active referral to 
Quitline. Medical and dental practitioners working in Indigenous health services such as the 
setting for this study should work with together to provide multidisciplinary smoking 
cessation support. More research into the potential for e‐cigs to be used as a harm reduction 
strategy among Indigenous Australians is warranted given the prevalence of smoking in this 
sample and that more than half indicated interest in using them in a quit attempt. 
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